Stephen A. Farkas

475 citations
8 papers · 349 indexed · h-index 7

Stephen A. Farkas

8 papers receiving 322 citations

Peers

Stephen A. Farkas
Comparison fields: 5 of 50
  • Applied Microbiology and Biotechnology 41
  • Critical Care and Intensive Care Medicine 96
  • Molecular Medicine 74
  • Epidemiology 222
  • Pharmacology 94
Replace George Koratzanis with:
George Koratzanis Greece
J. A. Romand Switzerland
J. Papadatos Greece
Angela Wills United States
Alejandro Torres Chile
Danièla Aymon Switzerland
Guillermo Rodriguez-Gomez United States
Yoann Zerbib France
J Eller Germany
C Floriot France
Stephen A. Farkas relative to George Koratzanis Greece George Koratzanis's profile →
Citations per field
00.5×1.5×2.2×
George Koratzanis · 1×
Citations per year

Countries citing papers authored by Stephen A. Farkas

Since Specialization
Citations

This map shows the geographic impact of Stephen A. Farkas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen A. Farkas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen A. Farkas more than expected).

Fields of papers citing papers by Stephen A. Farkas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephen A. Farkas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen A. Farkas. The network helps show where Stephen A. Farkas may publish in the future.

Co-authorship network

The 21 scholars most cited alongside Stephen A. Farkas, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Stephen A. Farkas Line = papers co-authored together Stephen A. Farkas links everyone, so they are left out of the graph.

All Works

8 of 8 papers shown
#Work
1 199850
2 1998139
3 199798
4 199710
5 199634
6 19938
7 19907
8 19783

About Stephen A. Farkas

Stephen A. Farkas is a scholar working on Molecular Medicine, Microbiology and Emergency Medical Services, having authored 8 papers that have together received 349 indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (3 papers), Pneumonia and Respiratory Infections (3 papers), Antibiotics Pharmacokinetics and Efficacy (1 paper), Cystic Fibrosis Research Advances (1 paper), Tuberculosis Research and Epidemiology (1 paper), Pediatric health and respiratory diseases (1 paper), Respiratory viral infections research (1 paper) and Hemophilia Treatment and Research (1 paper). The work is most often cited by research in Applied Microbiology and Biotechnology (41 citations), Critical Care and Intensive Care Medicine (96 citations) and Molecular Medicine (74 citations). Stephen A. Farkas has collaborated with scholars based in United States, New Zealand and Canada. Frequent co-authors include Ronald W. Geckler, Steven Berman, Ben deBoisblanc, Nick Fotheringham, Richard K. Root, John Wilson, David C. Dale, Richard W. Carlson, Thomas J. Marrie and Steve Nelson. Their work appears in journals such as Clinical Infectious Diseases, The American Journal of Medicine and The Journal of Infectious Diseases.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026